The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now!
Authors:
- Maciej BanachMBMaciej Banach
- Zlatko FrasZFZlatko Fras
- Dan GaitaDGDan Gaita
- Ivan PecinIPIvan Pecin
- Gani BajraktariGBGani Bajraktari
- Bojko BjelakovicBBBojko Bjelakovic
- Ibadete BytyciIbadete Bytyci
- Richard CeskaRCRichard Ceska
- Dragan DjuricDragan Djuric
- Robert J. GilRGRobert J. Gil
- Jacek JozwiakJJJacek Jozwiak
- Raimondas KubiliusRKRaimondas Kubilius
Open Access
- 9 January 2025
- journal article
- review article
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 103
Abstract
Cardiovascular diseases (CVDs) remain a leading global cause of mortality and disability, with significant disparities observed across countries. This is particularly true in Central and Eastern Europe (CEE), where populations are primarily at high and very high CVD risk. Highlighting modifiable risk factors underscores the urgent need for effective prevention programs. This paper introduces the European Program for Prevention (EPP), an initiative by the International Lipid Expert Panel (ILEP), designed to address these challenges. The EPP aims to enhance awareness and knowledge of validated preventive healthcare solutions implemented in CEE countries, showcase the region’s potential for innovative strategies, and evaluate the adaptability of successful programs for broader implementation. The EPP strongly supports the EU Cardiovascular Health Plan, as well as initiatives by the World Heart Federation (WHF) and World Health Organization (WHO), by promoting best practices, early detection, integrated prevention frameworks, training, cross-border cooperation, and policy development. It advocates shifting healthcare priorities towards pre-disease prevention, thus reducing reliance on resource-intensive treatments. The program proposes an optimal CVD prevention system that includes mandatory health education, screening programs for familial hypercholesterolemia and universal Lp(a) screening, and comprehensive check-ups, notably integrated, comprehensive care programs. By leveraging existing validated programs and fostering collaboration, the EPP seeks to reduce the burden of CVD, improve outcomes, and promote cardiovascular health across Europe and beyond.Keywords
This publication has 27 references indexed in Scilit:
- World health Organization’s guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoringeClinicalMedicine, 2025
- Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021The Lancet, 2025
- 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)Drugs, 2024
- Heart Failure Care in the Central and Eastern Europe and Baltic Region: Status, Barriers, and Routes to ImprovementESC Heart Failure, 2024
- Global Burden of Cardiovascular Diseases and Risks, 1990-2022JACC, 2023
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2023
- Lessons Learned From 10 Years of Preschool Intervention for Health PromotionJACC, 2022
- Trends in cardiovascular risk factor prevalence among Lithuanian middle-aged adults between 2009 and 2018Atherosclerosis, 2020
- Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature reviewAtherosclerosis, 2018
- Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapyInternational Journal of Cardiology, 2016